A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Clinical trial NCT06686615 · RECRUITING

Trial details

NCT number: NCT06686615
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Status: RECRUITING
Study type: OBSERVATIONAL

Primary Hypercholesterolemiia Mixed Dyslipidemia

Start date: 2025-02-12
Primary completion: 2027-07-31
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.